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Introduction/background
Treatment of Hemiplegic Migraine can be challenging.
Migraine-specific abortives, the triptans and ergota-
mines, are currently contraindicated in the treatment of
Hemiplegic Migraine because of their vasoconstrictive
properties.
Method
Case study to report the effects of OnabotulinumtoxinA
injections for the pain relief and long-term symptom
control in a patient with Hemiplegic Migraine. Case:
54-year-old woman with Hemiplegic Migraine for the
past 12 years. Severe migraines with right unilateral
retro-orbital pain, with progression to the left side, fol-
lowed by right facial weakness with complete ptosis on
the right side and less prominent left facial weakness,
immediately progressing to right hemiparesis and then
later to left hemiparesis. Attacks were accompanied with
nausea, vomiting, dysarthria and dysphasia. Migraine
and paralytic episodes 1/week lasting 3-5 days. Head-
ache frequency 20 days/month. Failed the following
therapy: Topamax, Epival and Memantine. Inconsis-
tently responded to IV Maxeran and Benadryl in ER.
First OnabotulinumtoxinA injections received in
September, 2009. 100 units of the toxin injected over
frontalis, corrugators, procerus, temporalis, occipitalis,
sub-occipital and splenius capitus bilaterally. Outcome
measures: Frequency of migraine and pain intensity
(mild, moderate, severe) and limb weakness was mea-
sured at baseline and at 90 days after treatment.
Results
Immediate and sustained response since first treatment
cycle. Frequency of Migraine episodes with paralysis
decreased from 12 to 2-3 episodes in 3 months. Migraine
severity decreased from severe to mild. Not a single ER
visit since! Mild facial weakness only during the attacks.
Migraine aborted by self administration of IM Maxeran
and Benadryl 2-3 times/3 months between injections.
Also on 100 mg of Amitriptylin all along. Effect of Ona-
botulinumtoxinA wears off in 3 months. No side effects
reported.
Conclusion
OnabotulinumtoxinA appears to help in alleviating
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